Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Netherlands
Zanamivir

CBG-MEB 2019

Zanamivir

Dectova 10 mg/ml, oplossing voor infusie

Oplossing voor infusieNetherlandsAuthorisedAuthorised 26 Apr 2019

Product informationAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

DectovaEuropean UnionAuthorised

Dectova 10 MG/ML Solucion Para PerfusionSpain · 200 mg · solución para perfusión · Glaxosmithkline Trading Services LimitedSame brand
DectovaEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
DectovaCroatiaSame brand
DectovaItaly · Soluzione per infusione · Glaxosmithkline Trading Services LimitedSame brand
RelenzaBrazil · Glaxosmithkline Brasil LtdaSame substance
RelenzaCanada · 5 MG / ACT · Powder · Glaxosmithkline INCSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

🇪🇸RELENZA 5 mg/dosis POLVO PARA INHALACIÓN (UNIDOSIS)Spain · 5 mg · polvo para inhalación · Glaxosmithkline S.A.Same substance

🇭🇷Relenza 5 mg/dozi, prašak inhalata, doziraniCroatia · prašak inhalata, dozirani · GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, IrskaSame substance

🇮🇹RelenzaItaly · Polvere per inalazione · Glaxosmithkline S.P.A.Same substance

🇳🇿Relenza RotadiskNew Zealand · Powder for inhalation 5 mgSame substance

🇷🇸Relenza®Serbia · 5mg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame substance

🇷🇸Relenza®Serbia · 5mg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame substance

🇷🇸Relenza®Serbia · 5mg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame substance

🇸🇦Relenza 5MG Powder for InhalationSaudi Arabia · GlaxowellcomeSame substance

🇸🇬RELENZA ROTADISK 5 mg/doseSingapore · 5 mg/dose · powder, metered · Glaxosmithkline Pte LTDSame substance

🇺🇸RelenzaUnited States · 5MG · powder · GlaxosmithklineSame substance

Documents

The official texts, at the regulator.

Summary of product characteristicsCBG-MEB
Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Zanamivir
Dosage form: Oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 26 Apr 2019
Registration: EU/1/18/1349
Marketing authorisation holder: GlaxoSmithKline Trading Services Limited
ATC code: J05AH01
Group: Anti-infectives for systemic use
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/004102
EU number: EU/1/18/1349